for the planet
We are determined to make firm commitments to protect the planet
The climate emergency and environmental degradation incite us to adopt measures to reduce greenhouse gas emissions and bolster efforts to protect biodiversity and preserve natural resources. We adopt a comprehensive and integrated approach across the entire medicine value chain.
Our sense of responsibility drives us to take action. Quickly.
In response to the climate emergency, we are committed to reducing our greenhouse gas emissions.
Supported by consultancy EcoAct, we measured our direct and indirect emissions in comparison with 2015-2016 as the base year. This enabled us to assess the progress already made and then structure our low-carbon strategy, which led us to pledge to reduce total CO2 emissions by 25% by 2030. Targets have been set to reduce each area, including energy, transportation, raw materials, business travels, etc.
They were approved in late 2019 by the Science Based Targets Initiative (SBTi), an international organization that guides companies through the climate transition.
In line with the Paris Agreement, Servier’s strategy seeks to reduce total CO2 emissions by 25% between 2016 and 2030, representing a decrease of 251,282 metric tons of CO2 equivalent.
We have already launched many initiatives at several of our facilities, for example to regenerate solvants, renovate buildings to enhance energy performance standards, purchase and generate renewable energy on site and develop sea freight as an alternative to air freight. As part of the partnership with EcoAct, we also offset a portion of our unavoidable residual emissions by funding carbon avoidance projects.
30,000
metric tons of CO2 equivalent were offset by Servier in 2022 through carbon avoidance projects
-13%
reduction in greenhouse gas emissions per box of medicines produced between 2016 and 2019
We once again underscored our commitment to protecting biodiversity when in 2021 we signed up to the Act4nature international initiative led by EpE (Entreprises pour l’Environnement).
Consequently, we comply with the 10 commitments set out by the intiative. We also took additional steps to:
We strive to achieve the highest standards at our future Research and Development Institute in Paris-Saclay:
We make firm commitments with respect to the impact of our operations on society and the environment. We do so all throughout the medicine life cycle through our EcoDesign by Servier program.
To develop the road map for the program, we used life cycle analysis methodology to assess the environmental aspects of medicines—i.e., through the design, extraction of raw materials, production, distribution, usage and end-of-life disposal.
The program helps to take better account of social and environmental considerations such as climate change, biodiversity and natural resources, in accordance with efficacy and therapeutic safety requirements.
We have also developed the “Green Score” system for use within the Group, which integrates the principles of sustainable chemistry, including ecotoxicity and climate impact. By 2023, 100% of new chemical syntheses will be given a Green Score.
We pledge to integrate eco-design principles to packaging for new brand-name medicines, in accordance with pharmaceutical regulations, between now and 2025.
